Seymour JF, Kipps TJ, Eichhorst B, et al. MURANO Trial Establishes Feasibility of Time-Limited Venetoclax-Rituximab (VenR) Combination Therapy in Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL). ASH Annual Meeting and Exposition 2018, abstract 184.
Effectiviteit en veiligheid van verlengde profylaxe met letermovir
apr 2024 | Leukemie, Lymfoom, MDS, Stamceltransplantatie, Virale infecties